BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7657477)

  • 1. The use of n-3 PUFAs (fish oil) in enteral nutrition.
    Gerster H
    Int J Vitam Nutr Res; 1995; 65(1):3-20. PubMed ID: 7657477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK; Kostkiewicz M
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.
    Calder PC
    Mol Nutr Food Res; 2008 Aug; 52(8):885-97. PubMed ID: 18504706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
    Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
    Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid composition abnormalities in atopic disease: evidence explored and role in the disease process examined.
    Sala-Vila A; Miles EA; Calder PC
    Clin Exp Allergy; 2008 Sep; 38(9):1432-50. PubMed ID: 18665842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression.
    Su KP
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():151-7. PubMed ID: 18296325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
    Rodríguez-Cruz M; Tovar AR; del Prado M; Torres N
    Rev Invest Clin; 2005; 57(3):457-72. PubMed ID: 16187707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish oil lipid emulsions and immune response: what clinicians need to know.
    Waitzberg DL; Torrinhas RS
    Nutr Clin Pract; 2009; 24(4):487-99. PubMed ID: 19605803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
    Russo GL
    Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine lipids: overview "news insights and lipid composition of Lyprinol".
    Sinclair AJ; Murphy KJ; Li D
    Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil in critical illness.
    Mayer K; Seeger W
    Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):121-7. PubMed ID: 18301086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 polyunsaturated fatty acids: benefit or harm during sepsis?
    Peck MD
    New Horiz; 1994 May; 2(2):230-6. PubMed ID: 7922448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats.
    Metcalf RG; James MJ; Mantzioris E; Cleland LG
    Eur J Clin Nutr; 2003 Dec; 57(12):1605-12. PubMed ID: 14647226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. n-3 fatty acids and the immune system in autoimmunity.
    Ergas D; Eilat E; Mendlovic S; Sthoeger ZM
    Isr Med Assoc J; 2002 Jan; 4(1):34-8. PubMed ID: 11802309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
    Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
    J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition.
    Dunstan JA; Roper J; Mitoulas L; Hartmann PE; Simmer K; Prescott SL
    Clin Exp Allergy; 2004 Aug; 34(8):1237-42. PubMed ID: 15298564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition.
    Dunstan JA; Mori TA; Barden A; Beilin LJ; Holt PG; Calder PC; Taylor AL; Prescott SL
    Eur J Clin Nutr; 2004 Mar; 58(3):429-37. PubMed ID: 14985680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)?
    Gerster H
    Int J Vitam Nutr Res; 1998; 68(3):159-73. PubMed ID: 9637947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.